Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:40 AM
Ignite Modification Date: 2025-12-25 @ 3:40 AM
NCT ID: NCT01287702
Eligibility Criteria: Inclusion Criteria: 1. The etiology of portal hypertension is cirrhosis. 2. Age ranges between 20-80 y/o. 3. Patients presenting with acute gastroesophageal variceal bleeding proven by emergency endoscopy within 12 hours. (Acute esophageal variceal bleeding was defined as: 1) when blood was directly seen by endoscopy to issue from an esophageal varix (active bleeding), or 2) when patients presented with red color signs on their esophageal varices with blood in esophagus or stomach and no other potential site of bleeding identified (inactive bleeding). Gastric variceal bleeding is defined as active spurting from a gastric varix or presence of red spots on a gastric varix. 4. EVL is performed after confirmation of acute esophageal variceal bleeding. Histoacryl injection is performed if acute gastric variceal bleeding is diagnosed. Bleeding is arrested on the spot. Exclusion Criteria: 1. association with severe systemic illness, such as sepsis, COPD, uremia, HCC, \> BCLC stage B 2. failure in the control of bleeding by emergency endoscopic treatment. 3. moribund patients, died within 12 hours of enrollment 4. Uncooperative 5. Ever received EIS, EVL within one month prior to index bleeding 6. Child-Pugh's scores \> 13 7. Deep jaundice (serum bilirubin \> 10 mg/dl), presence of encephalopathy \> stage II or massive ascites
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 80 Years
Study: NCT01287702
Study Brief:
Protocol Section: NCT01287702